BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc and Eidos Therapeutics Inc at Leerink Global Healthcare Conference Transcript

Feb 25, 2020 / 06:00PM GMT
Release Date Price: $31.94 (-3.94%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Good afternoon. I'm -- The floor is back from lunch. I'm Mani Foroohar, Managing Director and senior analyst here at SVB Leerink, covering genetic medicines, and I'm overjoyed to introduce the Neil Kumar.

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director

That's nice of you.

Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Of BridgeBio and Eidos Therapeutics. You -- so you're a CEO of 1/7 of my whole coverage universe right now.

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director

I guess that's a good thing.

Mani Foroohar;Neil Kumar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst

Do you want to hop through a couple of slides, talk about like, overview of the story?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot